Safety Use & Precautions Generally well-tolerated
This is the third Drug Safety-related Labeling Change (SrLC) since December 19, 2025, for the drug, according to the FDAs label change database
The majority of patients seeking GLP-1s present with one or more of the following: Insulin resistance or prediabetes PCOS or hormonal dysregulation Thyroid dysfunction Perimenopause-related metabolic changes Metabolic syndrome with multiple cardiovascular risk factors A platform that treats weight as the only relevant variable will miss most of these
Wang J, Li DL, Zheng LF, Ren S, Huang ZQ, Tao Y, Liu Z, Shang Y, Pang D, Guo H, et al
Telehealth as the New Frontline in Weight Management Telehealth platforms have proven to be more than just a convenient alternative to traditional healthcarethey have become a powerful tool for expanding access to specialized treatments
Bile acid toxicity in Paneth cells contributes to gut dysbiosis induced by high-fat feeding